Immunotherapy: Engineered T cells for all
Nature Reviews Cancer 17, 206 (2017).
doi:10.1038/nrc.2017.19
Author: Gemma K. Alderton
A report in Science Translational Medicine provides the first example of using universal engineered chimeric antigen receptor (CAR) T cells from human leukocyte antigen (HLA)-mismatched donors.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Gemma K. Alderton Tags: Research Highlight Source Type: research